Fig. 74From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseProposed binding mode of compound C87H docked at the active site of BACE1 [15]Back to article page